LIMITED WAIVER, CONSENT AND FIFTH AMENDMENT TO CREDIT AGREEMENTCredit Agreement • May 23rd, 2023 • Lifecore Biomedical, Inc. \De\ • Pharmaceutical preparations • New York
Contract Type FiledMay 23rd, 2023 Company Industry Jurisdiction
PLEDGE AND SECURITY AGREEMENT dated as of May 22, 2023 by and among EACH OF THE GRANTORS PARTY HERETO and ALCON RESEARCH, LLC, as Collateral AgentPledge and Security Agreement • May 23rd, 2023 • Lifecore Biomedical, Inc. \De\ • Pharmaceutical preparations
Contract Type FiledMay 23rd, 2023 Company IndustryThis PLEDGE AND SECURITY AGREEMENT, dated as of May 22, 2023 (this “Agreement”), is entered into by and among EACH OF THE UNDERSIGNED, whether as an original signatory hereto or as an Additional Grantor (as herein defined) (each, a “Grantor” and, collectively, the “Grantors”), and ALCON RESEARCH, LLC, as collateral agent for the Secured Parties (as herein defined) (in such capacity as collateral agent, the “Collateral Agent”).
EQUIPMENT LEASE AGREEMENTEquipment Lease Agreement • May 23rd, 2023 • Lifecore Biomedical, Inc. \De\ • Pharmaceutical preparations • New York
Contract Type FiledMay 23rd, 2023 Company Industry JurisdictionThis EQUIPMENT LEASE AGREEMENT dated as of May 22, 2023 (the “Effective Date”) (as the same may from time to time be amended, restated or otherwise modified this “Lease”) is made by and between ALCON RESEARCH, LLC, a Delaware limited liability company (the “Lessor”), and LIFECORE BIOMEDICAL, INC., a Delaware corporation (the “Lessee”).
EQUIPMENT SALE AND LEASEBACK AGREEMENTEquipment Sale and Leaseback Agreement • May 23rd, 2023 • Lifecore Biomedical, Inc. \De\ • Pharmaceutical preparations • New York
Contract Type FiledMay 23rd, 2023 Company Industry JurisdictionThis EQUIPMENT SALE AND LEASEBACK AGREEMENT (as the same may from time to time be amended, restated, or otherwise modified, this “Agreement”), dated and effective as of May 22, 2023 (the “Effective Date”), is entered into between Lifecore Biomedical, Inc., a Delaware corporation (“Seller”), and Alcon Research, LLC, a Delaware limited liability company (“Alcon”).
CREDIT AND GUARANTY AGREEMENT dated as of May 22, 2023, by and among LIFECORE BIOMEDICAL, INC. (F/K/A LANDEC CORPORATION), CURATION FOODS, INC., LIFECORE BIOMEDICAL OPERATING COMPANY, INC. (F/K/A LIFECORE BIOMEDICAL, INC.), as Borrowers, and certain...Credit and Guaranty Agreement • May 23rd, 2023 • Lifecore Biomedical, Inc. \De\ • Pharmaceutical preparations • New York
Contract Type FiledMay 23rd, 2023 Company Industry JurisdictionThis CREDIT AND GUARANTY AGREEMENT, dated as of May 22, 2023, is entered into by and among LIFECORE BIOMEDICAL, INC., a Delaware corporation (“Holdings”), CURATION FOODS, INC., a Delaware corporation (“Curation”), and LIFECORE BIOMEDICAL OPERATING COMPANY, INC., a Delaware corporation (“Lifecore” and together with Holdings and Curation, each, a “Borrower” and collectively, the “Borrowers”) as borrowers, the other Credit Parties party hereto from time to time, the Lenders party hereto from time to time and ALCON RESEARCH, LLC (“Alcon”), as Administrative Agent and Collateral Agent.
AMENDED AND RESTATED SUPPLY AGREEMENTSupply Agreement • May 23rd, 2023 • Lifecore Biomedical, Inc. \De\ • Pharmaceutical preparations • New York
Contract Type FiledMay 23rd, 2023 Company Industry JurisdictionTHIS AMENDED AND RESTATED SUPPLY AGREEMENT (the “Agreement”), effective as of the 3rd day of May, 2023 (the “Effective Date”), is by and between ALCON RESEARCH, LLC with its address at 6201 South Freeway, Fort Worth, TX 76134-2099 (hereinafter referred to as “ALCON”) and LIFECORE BIOMEDICAL, LLC, a Minnesota entity with its principal offices at 3515 Lyman Blvd., Chaska, Minnesota 55318 (hereinafter referred to as “SELLER”).